The Oncology Institute, Inc. (TOI)
USD 0.19
(-2.0%)
USD 0.19
(-2.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -83.06 Million USD | -4196.38% |
| 2022 | 1.65 Million USD | 115.16% |
| 2021 | -10.92 Million USD | 23.7% |
| 2020 | -14.32 Million USD | -256.13% |
| 2019 | -4.02 Million USD | -201.86% |
| 2018 | 3.94 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -12.67 Million USD | 4.87% |
| 2024 Q1 | -16.27 Million USD | -6.26% |
| 2023 Q1 | -29.99 Million USD | -215.7% |
| 2023 FY | -67.87 Million USD | -4196.38% |
| 2023 Q4 | -15.31 Million USD | 12.08% |
| 2023 Q2 | -16.89 Million USD | 43.67% |
| 2023 Q3 | -17.41 Million USD | -3.09% |
| 2022 Q4 | -9.5 Million USD | -255.35% |
| 2022 Q3 | -2.67 Million USD | 50.96% |
| 2022 Q2 | -5.45 Million USD | -134.58% |
| 2022 Q1 | 15.76 Million USD | 255.25% |
| 2022 FY | 1.65 Million USD | 115.16% |
| 2021 Q1 | -996 Thousand USD | 88.29% |
| 2021 Q2 | 3.2 Million USD | 421.79% |
| 2021 Q4 | -10.15 Million USD | -240.81% |
| 2021 Q3 | -2.98 Million USD | -192.98% |
| 2021 FY | -10.92 Million USD | 23.7% |
| 2020 Q3 | -2.41 Million USD | -337.35% |
| 2020 Q2 | 1.01 Million USD | 110.34% |
| 2020 Q1 | -9.84 Million USD | 0.0% |
| 2020 FY | -14.32 Million USD | -256.13% |
| 2020 Q4 | -8.5 Million USD | -252.1% |
| 2019 FY | -4.02 Million USD | -201.86% |
| 2018 Q4 | -1.99 Million USD | 0.0% |
| 2018 FY | 3.94 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | -21.66 Million USD | -283.385% |
| Addus HomeCare Corporation | 62.51 Million USD | 232.875% |
| AirSculpt Technologies, Inc. | -4.47 Million USD | -1754.61% |
| Amedisys, Inc. | -9.74 Million USD | -752.242% |
| American Oncology Network, Inc. | -5.54 Million USD | -1398.881% |
| Astrana Health, Inc. | 60.71 Million USD | 236.812% |
| Aveanna Healthcare Holdings Inc. | -134.52 Million USD | 38.25% |
| IMAC Holdings, Inc. | - USD | Infinity% |
| biote Corp. | 3.31 Million USD | 2605.066% |
| Cryo-Cell International, Inc. | -9.52 Million USD | -772.41% |
| Cross Country Healthcare, Inc. | 72.63 Million USD | 214.37% |
| COMPASS Pathways plc | -118.46 Million USD | 29.879% |
| DocGo Inc. | 6.85 Million USD | 1311.177% |
| The Ensign Group, Inc. | 209.39 Million USD | 139.67% |
| Healthcare Services Group, Inc. | 38.38 Million USD | 316.402% |
| InnovAge Holding Corp. | -21.33 Million USD | -289.296% |
| Assure Holdings Corp. | -26.07 Million USD | -218.537% |
| The Joint Corp. | -9.75 Million USD | -751.788% |
| LifeStance Health Group, Inc. | -186.26 Million USD | 55.403% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.6 Million USD | -432.392% |
| ModivCare Inc. | -204.46 Million USD | 59.372% |
| NewGenIvf Group Limited | 130.19 Thousand USD | 63903.738% |
| Novo Integrated Sciences, Inc. | -13.21 Million USD | -528.61% |
| Option Care Health, Inc. | 267.09 Million USD | 131.101% |
| P3 Health Partners Inc. | -57.77 Million USD | -43.783% |
| P3 Health Partners Inc. | -57.77 Million USD | -43.783% |
| The Pennant Group, Inc. | 13.37 Million USD | 720.883% |
| Surgery Partners, Inc. | -11.9 Million USD | -598.05% |
| Syra Health Corp. Class A Common Stock | -2.93 Million USD | -2727.036% |
| Talkspace, Inc. | -19.18 Million USD | -333.052% |
| Talkspace, Inc. | -19.18 Million USD | -333.052% |
| The Oncology Institute, Inc. | -83.06 Million USD | -0.0% |